RxDoctor Payments DataLook up a doctor →

Raul Couret, MD

Geriatric Medicine · Hendersonville, TNNPI 1306969696

Payments from drug & device makers

$6,221in general payments, 2019–2025

Across 371 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$909
  • AbbVie$593
  • Pfizer$588
  • Boehringer Ingelheim$470
  • Johnson & Johnson$392
  • Astellas Pharma US Inc$389
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$6,00296%
  • Education$2194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,221 in reported general payments places this provider in the 85th percentile of 46 geriatric medicine providers in Tennessee.

See all geriatric medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$158,778
Medicare patients
507
Services billed
3,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$92,255
EliquisApixaban164$87,168
MyrbetriqMirabegron195$80,435
JardianceEmpagliflozin62$74,327
XareltoRivaroxaban93$49,053
RybelsusSemaglutide28$36,368
TradjentaLinagliptin92$34,281
FarxigaDapagliflozin Propanediol60$30,431
Tresiba Flextouch U-200Insulin Degludec26$28,635
TrulicityDulaglutide25$28,584
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$22,587
Breo ElliptaFluticasone/Vilanterol39$21,316
AbrysvoRsv Vacc, Pref A And Pref B/Pf62$19,061
JanuviaSitagliptin Phosphate20$16,817
Bydureon BciseExenatide Microspheres14$14,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$909$128,624110 claims
Boehringer IngelheimJardiance, Tradjenta$470$108,607154 claims
PfizerEliquis, Abrysvo$588$106,229226 claims
Astellas Pharma US IncMyrbetriq$389$80,435195 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$322$58,06775 claims
Johnson & JohnsonXarelto$392$49,05393 claims
Lilly USA, LLCTrulicity, Mounjaro$180$40,65737 claims
AstraZenecaFarxiga, Symbicort$375$34,65573 claims
MerckJanuvia$73$16,81720 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$114$6,17114 claims
AbbVieSynthroid$593$5,00892 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 46 geriatric medicine providers in Tennessee.

Other geriatric medicine in Hendersonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →